Registry of Gastric Cancer Treatment Evaluation (REGATE): Variations in nonsurgical therapies. A phase II trial of nab-paclitaxel (NP) in patients with advanced pancreatic cancer (PC) who have ...
AFP, α-fetoprotein; AFP-L3, Lens culinaris agglutinin-reactive fraction of α-fetoprotein; PIVKA-II, protein induced by vitamin K absence or antagonist II; BCLC, Barcelona Clinic Liver Cancer; CLD, ...
ABC; An AGITG trial of fixed dose rate (FDR) gemcitabine (gem) and cisplatin for patients (pts) with advanced biliary tract cancer (ABC) ...
Serum alpha-fetoprotein (AFP) is the current standard of care and only approved biomarker for hepatocellular carcinoma (HCC), used for diagnosis, outcome prediction, long-term follow-up, and treatment ...
In patients at high risk for hepatocellular carcinoma (HCC), adding the serum biomarkers alpha-fetoprotein (AFP), the lectin-reactive fraction of AFP (AFP-L3), and des-gamma-carboxy prothrombin (DCP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results